骨量-肌量减少性肥胖与心血管疾病相关性研究进展

doi:10.3969/j.issn.1003-9198.2026.08.019

Abstract

Abstract: Osteosarcopenic obesity syndrome (OSO) has attracted much attention in recent years. This syndrome not only affects an individual’s bone and muscle health, but also closely related to the occurrence and development of cardiovascular diseases. This article reviews the diagnosis and epidemiological characteristics of OSO, the association mechanism between OSO and cardiovascular diseases, as well as relevant clinical evidence. It proposes that in the future, a unified diagnostic standard for OSO should be established, OSO-related indicators should be incorporated into cardiovascular disease risk assessment and management, and research on the shared pathological mechanisms and risk factors between OSO and cardiovascular diseases should be strengthened, ultimately aiming to construct a scientific and systematic diagnosis and treatment system.

Key words: osteosarcopenic obesity, cardiovascular diseases, osteoporosis, sarcopenia, obesity

CLC Number:

R 592
R 54

BU Xianghui, YANG Wei, YANG Shenshen, DENG Ting, ZHAO Yuan, WANG Weihua. Research progress on the association between osteosarcopenic obesity and cardiovascular diseases[J]. Practical Geriatrics, 2026, 40(8): 855-859.

References

[1] 万家敏, 赵柯湘, 孙悦, 等. 骨量-肌量减少性肥胖综合征与2型糖尿病关系的研究进展[J]. 中国全科医学, 2021, 24(9): 1152-1157.
[2] ILICH J Z, KELLY O J, INGLIS J E, et al.Interrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels[J]. Ageing Res Rev, 2014, 15: 51-60.
[3] 聂义珍, 闫朝岐, 燕巍, 等. 基于多元统计学方法的骨量肌量减少性肥胖综合征的结构特征研究[J]. 中国全科医学, 2022, 25(22): 2733-2739, 2745.
[4] 吕婷, 王晓云, 郑彭燕, 等. 老年人骨量-肌量减少性肥胖综合征患病率的Meta分析[J]. 中华临床营养杂志, 2026, 34(1): 27-34.
[5] PANG B W J, WEE S L, CHEN K K, et al. Coexistence of osteoporosis, sarcopenia and obesity in community-dwelling adults-The Yishun Study[J].Osteoporos Sarcopenia, 2021, 7(1):17-23.
[6] KUCHI BHOTLA H, MEYYAZHAGAN A, PUSHARAJ K, et al. Prevalence of cardiovascular diseases in South Asians: scrutinizing traditional risk factors and newly recognized risk factors sarcopenia and osteopenia/osteoporosis[J].Curr Probl Cardiol, 2024, 49(1 Pt B):102071.
[7] 张欣, 代火祥, 黄丽红. 心力衰竭与骨质疏松相关性的研究进展[J]. 中国心血管杂志, 2025, 30(5): 607-612.
[8] 李艳琪, 宋艳萍, 姚娜, 等. 骨量肌量减少性肥胖研究热点及趋势的可视化研究[J]. 运动科学与健康研究, 2025(4): 34-44.
[9] 盛丽春, 高静媛, 王明兰, 等. 骨量-肌量减少性肥胖综合征的研究进展[J]. 中国现代医生, 2024, 62(17): 118-121, 124.
[10] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2022)[J]. 中华骨质疏松和骨矿盐疾病杂志, 2022, 15(6): 573-611.
[11] 中华医学会老年医学分会, 国家老年疾病临床医学研究中心(湘雅医院). 中国肌肉减少症诊疗指南(2024版)[J]. 中华医学杂志, 2025, 105(03): 181-203.
[12] 曲伸, 陆灏, 宋勇峰. 基于临床的肥胖症多学科诊疗共识(2021年版)[J]. 中华肥胖与代谢病电子杂志, 2021, 7(4): 211-226.
[13] LIU Y, SONG Y, HAO Q, et al. Global prevalence of osteosarcopenic obesity amongst middle aged and older adults: a systematic review and meta-analysis[J]. Arch Osteoporos, 2023, 18(1): 60.
[14] MA Y, ZHANG W, HAN P, et al.Osteosarcopenic obesity associated with poor physical performance in the elderly Chinese community[J]. Clin Interv Aging, 2020, 15: 1343-1352.
[15] MO D, HSIEH P, YU H, et al.Osteosarcopenic obesity and its relationship with dyslipidemia in women from different ethnic groups of China[J]. Arch Osteoporos, 2018, 13(1): 65.
[16] LIM H S, KIM D K, GIL H I, et al. Association of pulmonary function with osteosarcopenic obesity in older adults aged over 50 years[J]. Nutrients, 2023, 15(13): 2933.
[17] CHUCHERD O, VALLIBHAKARA O, VALLIBHAKARA S A, et al. Association of sarcopenic obesity and osteoporosis in postmenopausal women: risk factors and protective effects of hormonal therapy and nutritional status[J]. Arch Osteoporos, 2025, 20(1): 83.
[18] CHUNG J H, HWANG H J, SHIN H Y, et al.Association between sarcopenic obesity and bone mineral density in middle-aged and elderly Korean[J]. Ann Nutr Metab, 2016, 68(2): 77-84.
[19] AHMADINEZHAD M, MANSOURNIA M A, FAHIMFAR N, et al. Prevalence of osteosarcopenic obesity and related factors among Iranian older people: Bushehr Elderly Health (BEH) program[J]. Arch Osteoporos, 2023, 18(1): 137.
[20] HENG M W Y, CHAN A W D, MAN R E K, et al. Individual and combined associations of sarcopenia, osteoporosis and obesity with frailty in a multi-ethnic Asian older adult population[J]. BMC Geriatr, 2023, 23(1): 802.
[21] KELLY O J, GILMAN J C, BOSCHIERO D, et al.Osteosarcopenic obesity: current knowledge, revised identification criteria and treatment principles[J]. Nutrients, 2019, 11(4): 747.
[22] 陈恒亭, 马剑雄, 卢斌, 等. 骨量-肌量减少性肥胖综合征与骨折关系的研究进展[J]. 中华老年医学杂志, 2018, 37(3): 347-350.
[23] TAO J, LI H, WANG H, et al.Metabolic dysfunction-associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity[J]. Osteoporos Int, 2024, 35(12): 2087-2098.
[24] LIU Y, LIU Y, HUANG Y, et al. The effect of overweight or obesity on osteoporosis:a systematic review and meta-analysis[J]. Clin Nutr, 2023, 42(12): 2457-2467.
[25] 唐楠, 高远, 苏清清, 等. 老年骨质疏松患者再骨折影响因素分析及护理对策[J]. 中华护理杂志, 2025, 60(6): 710-716.
[26] KIM G, KIM J H. Impact of skeletal muscle mass on metabolic health[J]. Endocrinol Metab: Seoul, 2020, 35(1): 1-6.
[27] SANTHANAM L, LIU G, JANDU S, et al. Skeleton-secreted PDGF-BB mediates arterial stiffening[J]. J Clin Invest, 2021, 131(20): e147116.
[28] 张永政, 王荷晴, 崔立敏. 骨量-肌量减少性肥胖与衰弱相关性研究进展[J]. 护理研究, 2025, 39(13): 2307-2311.
[29] DOBRE M Z, VIRGOLICI B, CIOARCÃ-NEDELCU R. Lipidhormones at the intersection of metabolic imbalances and endocrine disorders[J]. Curr Issues Mol Biol, 2025, 47(7): 565.
[30] MACLEOD M, PRICE J, TSONOU E, et al. Adipose-derived extracellular vesicles and intercellular crosstalk with skeletal muscle: implications for sarcopenic obesity and metabolic dysregulation[J]. Obes Rev, 2026, 27(1): 1-22.
[31] LU L, TIAN L. Postmenopausal osteoporosis coexisting with sarcopenia: the role and mechanisms of estrogen[J]. J Endocrinol, 2023, 259(1): e230116.
[32] MCCOSKEY M, VERNON N. Male reproductive endocrine disorders[J]. Prim Care, 2024, 51(3): 455-466.
[33] NOBOA M E R, TSKHAKAIA I, ANDREWS J S. Comorbidities in idiopathic inflammatory myopathies: population-based evidence on risk subgroups and implications for delivery of care[J]. Curr Opin Rheumatol, 2026, 38(2): 76-82.
[34] DELONG A, FRIEDMAN M A, TUCKER S M, et al. Protective effects of controlled mechanical loading of bone in C57BL6/J mice subject to disuse[J]. JBMR Plus, 2019, 4(3): e10322.
[35] DAMLUJI A A, ALFARAIDHY M, ALHAJRI N, et al. Sarcopenia and cardiovascular diseases[J]. Circulation, 2023, 147(20): 1534-1553.
[36] VALLEJO J A, GRAY M, KLUMP J, et al. Bone mechanical loading reduces heart rate and increases heart rate variability in mice[J]. Bone Rep, 2025, 25: 101844.
[37] ILICH J Z, POKIMICA B, RISTIĆ-MEDIĆ D, et al.Osteosarcopenic adiposity (OSA) phenotype and its connection with cardiometabolic disorders: is there a cause-and-effect?[J]. Ageing Res Rev, 2024, 98: 102326.
[38] 陈兴才, 孔存青, 徐林, 等. 骨质疏松性少肌性肥胖综合征的诊断、治疗及相关影响因素[J]. 中国组织工程研究, 2020, 24(11): 1777-1782.
[39] HAMASAKI H. Obesity paradox in individuals with type 1 diabetes[J]. Front Clin Diabetes Healthc, 2025, 6: 1670312.
[40] ALEBNA P L, MEHTA A, YEHYA A, et al. Update on obesity, the obesity paradox, and obesity management in heart failure[J]. Prog Cardiovasc Dis, 2024, 82: 34-42.

Research progress on the association between osteosarcopenic obesity and cardiovascular diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Recommended 10

[1]	YU Xinxue, JIN Di, QUAN Jingwen, JIANG Juan, LIU Juanzi, WEI Yuanhao, XIE Hong, HUANG Jinmei, XU Xi. Development of a sarcopenia screening model for hospitalized elderly patients based on calf circumference, body mass index, and geriatric nutritional risk index [J]. Practical Geriatrics, 2026, 40(8): 805-810.
[2]	GAO Xinyu, KONG Xiaoming, GENG Hao, LYU Siwen. Effect of sarcopenia on episodic memory function in patients with late-life depression [J]. Practical Geriatrics, 2026, 40(8): 831-836.
[3]	WANG Wanhong, SUN Wenyu, ZHANG Yu, QIU Zhengang, LI Changhao, ZHANG Xin. Exploring the comorbidity mechanism and treatment strategies of inflammatory bowel disease and sarcopenia in the elderly based on the gut microbiota-brain-muscle axis [J]. Practical Geriatrics, 2026, 40(6): 630-634.
[4]	LUO Zhengxuan, JIA Jian, JIANG Yan, TU Jiawen, XU Zhiyang, ZHAN Yiyang. Advances in the application of wearable devices in geriatric cardiac rehabilitation [J]. Practical Geriatrics, 2026, 40(5): 520-524.
[5]	CHEN Yixiao, LIAO Hualong, LIN Taiping, YUE Jirong. Research progress on sarcopenia screening based on biomechanical characteristics and wearable devices [J]. Practical Geriatrics, 2026, 40(5): 530-535.
[6]	WEI Meihui, SHI Wei, CHEN Xi, XU Xinrong, PAN Li. Association between a body shape index and age-related macular degeneration [J]. Practical Geriatrics, 2026, 40(4): 372-376.
[7]	HAN Xingyan, GAO Fei. Research progress of FSH-FSHR signaling pathway in type 2 diabetic osteoporosis [J]. Practical Geriatrics, 2026, 40(4): 422-426.
[8]	SUN Kexin, LEI Jiawei, ZHANG Guilei, YANG Zhenrong, WANG Jiahe. Research progress on drug targets for the treatment of sarcopenia in the elderly [J]. Practical Geriatrics, 2026, 40(3): 229-233.
[9]	LIU Yue, XUE Qing, LIU Zekun, LIU Bing, QI Hao. Gut microbiota-immune axis: a new perspective on the pathogenesis and therapeutic interventions for postmenopausal osteoporosis [J]. Practical Geriatrics, 2026, 40(3): 304-308.
[10]	SHI Haiyan, MA Yan, GUO Ruifang. Molecular mechanisms of gut microbiota-derived metabolites in regulating skeletal muscle homeostasis and their significance for frailty [J]. Practical Geriatrics, 2026, 40(2): 185-190.
[11]	LI Pengli, YUAN Yiwei, ZHANG Fangshu, XU Jingwen. Advances in exercise interventions with different intensities for sarcopenia in the elderly [J]. Practical Geriatrics, 2026, 40(2): 196-200.
[12]	ZHOU Min, ZHOU Jiankun. Predictive effect of dietary inflammatory index on the onset of sarcopenia in elderly patients with chronic obstructive pulmonary disease [J]. Practical Geriatrics, 2026, 40(1): 53-56.
[13]	HE Haihua, LIU Gaoshuang, OUYANG Xiaojun. Effects and mechanisms of probiotics on sarcopenia complicated with cognitive impairment [J]. Practical Geriatrics, 2026, 40(1): 83-88.
[14]	ZHANG Chuqiong, OUYANG Gang, JIANG Jinfeng. Effect of acupuncture on the abundance of Lactobacillus reuteri and expression of related inflammatory factors in ovariectomy model rats [J]. Practical Geriatrics, 2025, 39(9): 883-887.
[15]	WANG Miaohui, FAN Xuhang, CHEN Siyao, YANG Xiaojuan. Research progress on the correlation between Alzheimer’s disease and osteoporosis [J]. Practical Geriatrics, 2025, 39(9): 937-941.